Heterogeneous distribution of K-ras mutations in primary colon carcinomas: Implications for EGFR-directed therapy

International Journal of Colorectal Disease

Volumn 26, Issue 10, 2011, Pages 1271-1277

  Oltedal, Satu ^a   Aasprong, Ole Gunnar ^a   Møller, Jannicke H ^a   Kørner, Hartwig ^a,b   Gilje, Bjørnar ^a   Tjensvoll, Kjersti ^a   Birkemeyer, Elke M ^a   Heikkilä, Reino ^a,c   Smaaland, Rune ^a,b   Nordgård, Oddmund ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Total Norge A/S   (Norway)

Author keywords

Colon cancer; EGFR; Heterogeneity; K ras mutations

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER THERAPY; CODON; COLON CARCINOMA; CONTROLLED STUDY; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE; TISSUE SECTION; TUMOR BIOPSY; TUMOR DIFFERENTIATION;

EID: 80855144158     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-011-1233-5     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249
2. Jiang Y, Kimchi ET, Staveley-O'Carroll KF, Cheng H, Ajani JA (2009) Assessment of K-ras mutation: A step toward personalized medicine for patients with colorectal cancer. Cancer 115:3609-3617
3. Allegra CJ, Jessup JM, Somerfield MR, Hamilton SR, Hammond EH, Hayes DF, McAllister PK, Morton RF, Schilsky RL (2009) American Society of Clinical Oncology provisional clinical opinion: Testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to antiepidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 27:2091-2096
4. Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, Juan T, Sikorski R, Suggs S, Radinsky R, Patterson SD, Chang DD (2008) Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 26:1626-1634
5. Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR (2008) K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359:1757-1765
6. Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A (2009) Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst 101:1308-1324
7. Andreyev HJ, Norman AR, Cunningham D, Oates JR, Clarke PA (1998) Kirsten ras mutations in patients with colorectal cancer: The multicenter "RASCAL" study. J Natl Cancer Inst 90:675-684 (Pubitemid 28222141)
8. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532
9. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767
10. Losi L, Baisse B, Bouzourene H, Benhattar J (2005) Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis 26:916-922 (Pubitemid 41214320)
11. Baisse B, Bouzourene H, Saraga EP, Bosman FT, Benhattar J (2001) Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma. Int J Cancer 93:346-352 (Pubitemid 32592052)
12. Giaretti W, Monaco R, Pujic N, Rapallo A, Nigro S, Geido E (1996) Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: Association with degree of DNA aneuploidy. Am J Pathol 149:237-245 (Pubitemid 26230995)
13. Ishii M, Sugai T, Habano W, Nakamura S (2004) Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas. J Gastroenterol 39:544-549 (Pubitemid 38996896)
14. Fukunari H, Iwama T, Sugihara K, Miyaki M (2003) Intratumoral heterogeneity of genetic changes in primary colorectal carcinomas with metastasis. Surg Today 33:408-413 (Pubitemid 36648886)
15. Al-Mulla F, Going JJ, Sowden ET, Winter A, Pickford IR, Birnie GD (1998) Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol 185:130-138 (Pubitemid 28270924)
16. Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE (2010) Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin Cancer Res 16:790-799
17. Shibata D, Schaeffer J, Li ZH, Capella G, Perucho M (1993) Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. J Natl Cancer Inst 85:1058-1063 (Pubitemid 23199186)
18. Dix BR, Robbins PD, Spagnolo DV, Padovan GL, House AK, Iacopetta BJ (1995) Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers. Diagn Mol Pathol 4:261-265
19. Thiede C, Bayerdorffer E, Blasczyk R, Wittig B, Neubauer A (1996) Simple and sensitive detection of mutations in the ras proto-oncogenes using PNA-mediated PCR clamping. Nucleic Acids Res 24:983-984 (Pubitemid 26076209)
20. Taback B, Bilchik AJ, Saha S, Nakayama T, Wiese DA, Turner RR, Kuo CT, Hoon DS (2004) Peptide nucleic acid clamp PCR: A novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes. Int J Cancer 111:409-414 (Pubitemid 38998822)
21. Gilje B, Heikkilä R, Oltedal S, Tjensvoll K, Nordgard O (2008) High-fidelity DNA polymerase enhances the sensitivity of a peptide nucleic acid clamp PCR assay for K-ras mutations. J Mol Diagn 10:325-331 (Pubitemid 352019118)
22. Oltedal S, Gilje B, Kørner H, Aasprong OG, Tjensvoll K, Heikkila R, Smaaland R, Nordgard O (2010) Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCR. Ann Surg 251:1087-1091
23. Nordgard O, Oltedal S, Kørner H, Aasprong OG, Tjensvoll K, Gilje B, Heikkilä R (2009) Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach. Ann Surg 249:602-607
24. Tortola S, Steinert R, Hantschick M, Peinado MA, Gastinger I, Stosiek P, Lippert H, Schlegel W, Reymond MA (2001) Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer. J Clin Oncol 19:2837-2843 (Pubitemid 32538192)
25. Zauber P, Sabbath-Solitare M, Marotta SP, Bishop DT (2003) Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas. Mol Pathol 56:137-140 (Pubitemid 36724225)
26. Santini D, Loupakis F, Vincenzi B, Floriani I, Stasi I, Canestrari E, Rulli E, Maltese PE, Andreoni F, Masi G, Graziano F, Baldi GG, Salvatore L, Russo A, Perrone G, Tommasino MR, Magnani M, Falcone A, Tonini G, Ruzzo A (2008) High concordance of KRAS status between primary colorectal tumors and related metastatic sites: Implications for clinical practice. Oncologist 13:1270-1275
27. Italiano A, Hostein I, Soubeyran I, Fabas T, Benchimol D, Evrard S, Gugenheim J, Becouarn Y, Brunet R, Fonck M, Francois E, Saint-Paul MC, Pedeutour F (2010) KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: Biological and clinical implications. Ann Surg Oncol 17:1429-1434
28. Al-Mulla F, Milner-White EJ, Going JJ, Birnie GD (1999) Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression. J Pathol 187:433-438 (Pubitemid 29118275)
29. Seeburg PH, Colby WW, Capon DJ, Goeddel DV, Levinson AD (1984) Biological properties of human c-Ha-ras1 genes mutated at codon 12. Nature 312:71-75 (Pubitemid 14010267)
30. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 8:755-768
31. Weinberg RA (2006) The biology of cancer. Garland science. Taylor and Francis, New York
32. Artale S, Sartore-Bianchi A, Veronese SM, Gambi V, Sarnataro CS, Gambacorta M, Lauricella C, Siena S (2008) Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer. J Clin Oncol 26:4217-4219
33. Mancuso A, Sollami R, Recine F, Cerbone L,MacciomeiMC, Leone A (2010) Patient with colorectal cancer with heterogeneous KRAS molecular status responding to cetuximab-based chemotherapy. J Clin Oncol 28:e756-e758
34. Bouchahda M, Karaboue A, Saffroy R, Innominato P, Gorden L, Guettier C, Adam R, Levi F (2010) Acquired KRAS mutations during progression of colorectal cancer metastases: Possible implications for therapy and prognosis. Cancer Chemother Pharmacol 66:605-609
35. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ, Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J, Tompkins RG, Lynch TJ, Toner M, Haber DA (2008) Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359:366-377